526 related articles for article (PubMed ID: 16105858)
1. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.
Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW
J Biol Chem; 2004 Feb; 279(9):7636-42. PubMed ID: 14668345
[TBL] [Abstract][Full Text] [Related]
4. Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice.
Hager L; Li L; Pun H; Liu L; Hossain MA; Maguire GF; Naples M; Baker C; Magomedova L; Tam J; Adeli K; Cummins CL; Connelly PW; Ng DS
J Biol Chem; 2012 Jun; 287(24):20755-68. PubMed ID: 22500017
[TBL] [Abstract][Full Text] [Related]
5. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
6. Acyl-coenzyme A binding protein expression alters liver fatty acyl-coenzyme A metabolism.
Huang H; Atshaves BP; Frolov A; Kier AB; Schroeder F
Biochemistry; 2005 Aug; 44(30):10282-97. PubMed ID: 16042405
[TBL] [Abstract][Full Text] [Related]
7. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
[TBL] [Abstract][Full Text] [Related]
8. LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling.
Li L; Naples M; Song H; Yuan R; Ye F; Shafi S; Adeli K; Ng DS
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E587-94. PubMed ID: 17551001
[TBL] [Abstract][Full Text] [Related]
9. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
11. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure.
Liang K; Vaziri ND
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E676-81. PubMed ID: 12217884
[TBL] [Abstract][Full Text] [Related]
13. Lupin protein influences the expression of hepatic genes involved in fatty acid synthesis and triacylglycerol hydrolysis of adult rats.
Bettzieche A; Brandsch C; Weisse K; Hirche F; Eder K; Stangl GI
Br J Nutr; 2008 May; 99(5):952-62. PubMed ID: 18096091
[TBL] [Abstract][Full Text] [Related]
14. Age-related alteration in hepatic acyl-CoA: cholesterol acyltransferase and its relation to LDL receptor and MAPK.
Bose C; Bhuvaneswaran C; Udupa KB
Mech Ageing Dev; 2005; 126(6-7):740-51. PubMed ID: 15888329
[TBL] [Abstract][Full Text] [Related]
15. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.
Chakravarthy MV; Pan Z; Zhu Y; Tordjman K; Schneider JG; Coleman T; Turk J; Semenkovich CF
Cell Metab; 2005 May; 1(5):309-22. PubMed ID: 16054078
[TBL] [Abstract][Full Text] [Related]
16. Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion.
Zaiden N; Yap WN; Ong S; Xu CH; Teo VH; Chang CP; Zhang XW; Nesaretnam K; Shiba S; Yap YL
J Atheroscler Thromb; 2010 Oct; 17(10):1019-32. PubMed ID: 20702976
[TBL] [Abstract][Full Text] [Related]
17. An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet.
Mutch DM; Grigorov M; Berger A; Fay LB; Roberts MA; Watkins SM; Williamson G; German JB
FASEB J; 2005 Apr; 19(6):599-601. PubMed ID: 15670975
[TBL] [Abstract][Full Text] [Related]
18. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice.
Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188
[TBL] [Abstract][Full Text] [Related]
19. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet.
Tanaka Y; Aleksunes LM; Yeager RL; Gyamfi MA; Esterly N; Guo GL; Klaassen CD
J Pharmacol Exp Ther; 2008 May; 325(2):655-64. PubMed ID: 18281592
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.
Arnauld S; Fidaleo M; Clémencet MC; Chevillard G; Athias A; Gresti J; Wanders RJ; Latruffe N; Nicolas-Francès V; Mandard S
Biochimie; 2009; 91(11-12):1376-86. PubMed ID: 19772884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
